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The expression of avb3 integrin was examined in human skeletal muscle cells grown in vitro. The av and b3 subunits
showed different patterns of expression during myogenesis. Expression of the av subunit did not change signi®cantly during
the growth and differentiation of muscle cells, whereas expression of the b3 subunit was markedly down-regulated at both
the message and protein levels. Down-regulation of b3 subunit expression did not occur when cultures were treated
with 5-bromo-2*-deoxyuridine to inhibit myoblast terminal differentiation, but did occur in cultures in which fusion was
selectively inhibited by growth in EGTA-containing medium. These results suggest that the regulation of integrin b3
subunit expression is tightly coupled to the myogenic terminal differentiation program, but is not simply a consequence
of membrane reorganization due to the fusion process. Several stably transfected lines of mouse C2 myoblasts were derived
from cultures transfected with a cDNA encoding the complete human b3 integrin sequence under the control of the CMV
promoter. Lines which constitutively expressed high levels of the human b3 integrin subunit did not fuse or biochemically
differentiate, whereas lines expressing moderate levels of the b3 integrin subunit showed delayed fusion and differentiation.
Lines expressing very low to undetectable levels of the human b3 integrin subunit exhibited unimpaired fusion and
differentiation. Taken together these results suggest (i) that down-regulation of avb3 integrin normally occurs as part
of the myogenic terminal differentiation program, (ii) that this is mediated by regulation of the expression of the b3
subunit, and (iii) that down-regulation of expression of the b3 integrin subunit appears essential for myoblast differentia-
tion. q 1997 Academic Press
INTRODUCTION 1989; OÈ calan et al., 1988). Adhesion to proteins of the ECM
is largely mediated by the integrin superfamily of adhesion
Skeletal myogenesis is a dynamic process which is de- proteins. Integrins are heterodimeric, transmembraneous
®ned by a series of successive changes in gene expression glycoproteins which, by simultaneously binding to proteins
and cellular behaviour. Important protein cues are present of the ECM and cytoskeleton, can mediate the exchange
in the extracellular matrix (ECM) which may direct and of information between the extracellular and intracellular
regulate such diverse cellular events as proliferation and compartments of the cell (Ruoslahti et al., 1994; Hynes,
migration and may further assist in choreographing the 1992).
complex series of events which characterizes myogenic ter- The b1 subfamily of integrins has been suspected for
minal differentiation (Knudsen and Horwitz, 1994; Knud- some time of playing a critical role in muscle cell terminal
sen, 1990; Chung and Kang, 1990; von der Mark and OÈ calan, differentiation (Menko and Boettiger, 1987). Levels of at
least three b1 integrins (a4b1, a5b1, and a7b1 integrins) are
known to be regulated during myogenesis in vivo (George-1 To whom correspondence should be addressed at Room 665,
Weinstein et al., 1993; Rosen et al., 1991; 1992; Song et al.,Montreal Neurological Institute, 3801 University Street, Montreal,
1992; Enomoto et al., 1993; Blaschuk and Holland, 1994).Quebec, Canada H3A 2B4. Fax: (514) 398-1509. E-mail: cxhp@
musica.mcgill.ca. Levels of expression of a7b1 and a4b1 integrins increase
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during myogenesis. a7b1 integrin mediates adhesion to ®- that human skeletal muscle satellite cells express avb3 in-
tegrin, that down-regulation of this integrin is tightly cou-bronectin and laminin (Gu et al., 1994). It is thought to play
a role in myoblast proliferation during the secondary wave pled to myogenic terminal differentiation by transcriptional
regulation of the expression of the b3 subunit, and thatof myogenesis (Song et al., 1992) and it localizes to the
myotendinous junction in mature muscle (Bao et al., 1993). overexpression of the b3 subunit inhibits myoblast differen-
tiation in a dose-dependent manner.a4b1 integrin may be involved in myoblast fusion by form-
ing heterotypic cell±cell adhesions with its cognate recep-
tor, VCAM-1 (Rosen et al., 1992). a5b1 integrin binds to
®bronectin and is a component of adhesion plaques in myo-
blasts and myotubes (Enomoto et al., 1993). a5b1 integrin MATERIALS AND METHODS
undergoes marked changes in distribution (Enomoto et al.,
1993), activation (Boettiger et al., 1995), and expression
Cell Culture(Blaschuk and Holland, 1994) during myogenesis. Levels of
a5b1 integrin are down-regulated during myogenesis, but Human biceps muscle biopsies were obtained from patients pre-
expression is regulated by the availability of exogenous senting with suspected neuromuscular disease who were subse-
growth factors rather than directly by the myogenic termi- quently found to have no discernable muscle pathology. Satellite
nal differentiation program (Blaschuk and Holland, 1994). cells were isolated from biopsy discard material and cloned by serial
Since a5b1 integrin can play a critical role in regulation dilution to remove contaminating ®broblasts (Champaneria et al.,
1989). Cells were maintained in growth medium (Ham's F12, Gibcoof the cell cycle in other cell types (Symington, 1992) we
BRL, Burlington, Ont.) supplemented with 0.5 mg/ml BSA (Sigma,postulated that regulation of expression of a5b1 integrin
St. Louis, MO), 0.4 mg/ml dexamethasone (Sigma), 10 ng/ml humanby exogenous growth factors may be an important factor
recombinant EGF (R & D Systems, Minneapolis, MN), 0.5 mg/mlcontributing to the transition of myoblasts from a prolifera-
fetuin (Sigma), 0.18 mg/ml insulin (Sigma), and 15% v/v fetal calftive to a differentiated state during myogenesis (Blaschuk
serum (Gibco BRL) after the method of Ham et al. (1988). To induce
and Holland, 1994). Accordingly, it has recently been shown differentiation, cultures were switched to fusion medium (DMEM,
that ectopic expression of the a5 integrin subunit causes Gibco BRL) supplemented with 2% v/v horse serum (Gibco BRL)
quail myoblasts to remain in the proliferative state and in- (Ham et al., 1990, 1988).
hibits their terminal differentiation (Sastry et al., 1996). In
contrast, ectopic expression of the a6 integrin subunit,
which is believed to bind to laminin, inhibited proliferation
Western Blot Analysisand promoted differentiation (Sastry et al., 1996). From
these studies the concept has emerged that integrin a sub-
Western blot analysis was performed as previously describedunit ratios are a critical factor contributing to the decision
with modi®cation (Blaschuk and Holland, 1994). Human satellite
of skeletal myoblasts to withdraw from the proliferative cells were solubilized in sample buffer (2% SDS, 10% glycerol, 125
state and initiate terminal differentiation (Sastry et al., mM Tris±HCl, pH 6.8) and the protein concentration was deter-
1996). mined by the DC microplate protein assay (Bio-Rad, Mississauga,
In contrast to the b1 subfamily, little is known regarding Ont.). Samples (12 mg protein) were separated by SDS/PAGE on
7% (w/v) acrylamide gels under nonreducing conditions and thethe expression of other integrins during myogenesis. Inte-
separated proteins were transferred electrophoretically onto nitro-grins containing the av subunit constitute another large
cellulose membranes (Schleicher & Schuell, Keene, NH). The re-subfamily which mediates adhesion to ECM proteins
sulting blots were probed overnight at 47C with one of the follow-(Heino, 1993). One member (avb3 integrin) may be of partic-
ing: monoclonal anti-human av integrin (clone VNR 139, Gibcoular relevance to myogenesis since it interacts with ®bro-
BRL, diluted 1:1000), polyclonal anti-rat b1 integrin (a gift of Dr.nectin, laminin, and collagens I and IV (Clyman et al., 1992;
S. Carbonetto, McGill University, Montreal, Que., diluted 1:1000)
Charo et al., 1990), which are also major protein constit- or anti-b3 integrin (monoclonal anti-human CD61, Serotec Canada,
uents of the ECM of developing skeletal muscle (Sanes, Toronto, Ont., Cat. No. MCA 728, diluted 1:400,), rabbit polyclonal
1994). Further, avb3 integrin has been suggested to regulate antiserum to a5 integrin (Blaschuk and Holland, 1994, diluted
tumor growth in vivo (Juliano and Varner, 1993; Felding- 1:1000). Secondary antibodies used, where appropriate, were either
peroxidase-conjugated anti-mouse IgG (diluted 1:5000, Bio/Can Sci-Habermann et al., 1992) and is known to play a central role
enti®c Inc., Mississuaga, Ont.) or peroxidase-conjugated anti-rabbitin cellular migration during angiogenesis (Yue et al., 1994;
IgG (diluted 1:5,000, Bio/Can Scienti®c Inc., Mississuaga, Ont.).Leavesley et al., 1993; Clyman et al., 1992; Cheng et al.,
Immobilized antigen was detected by enhanced chemilumines-1991) and tumor metastasis (Heino, 1993; Felding-Ha-
cence (ECL, Amersham, Oakville, Ont.). Immunoreactive bandsbermann and Cheresh, 1993; Juliano and Varner, 1993; Al-
were quantitated and corrected for background using a JAVA videobelda, 1993). The expression of avb3 integrin is also up-
analysis software package (Jandel Scienti®c, Corte Madera, CA). To
regulated by TGF-b1 (Ignotz et al., 1989) and phorbol esters ensure immunoreactive bands were quantitated in the linear range
(Swerlick et al., 1992; Zutter et al., 1992; Silver et al., 1987), each luminol-treated blot was exposed to ®lm for several different
both of which are also inhibitory to myogenesis (Vaidya et periods, to determine when saturation of the ®lm occurred for each
al., 1989; Dlugosz et al., 1983; Fisher et al., 1983, 1982; band. Comparisons between bands were only made using ®lms in
which no band had yet achieved saturation density.Cohen et al., 1977). In the present study, we demonstrate
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TABLE 1
Effects of EGTA Treatment on Terminal Differentiation and Levels of b3 Integrin Subunit Expressiona
Fusion indexb Creatine kinase activityc b3 integrin subunit levelsd
Culture conditions (% nuclei in myotubes) (mmole/min/mg soluble protein) (pixel density)
Con¯uence 1.6 { 0.4 0.02 { 0.003 44 { 2.3 (1.0)
F12 5.6 { 1.3 0.02 { 0.002 33 { 1.9 (0.75)
FM 69 { 1.7 3.8 { 0.17 15 { 2.6 (0.34)
FM / 1.6 mM EGTA 7.8 { 1.0 2.7 { 0.37 13 { 3.5 (0.30)
a Culture conditionsÐCells were grown in F12 supplemented medium as described under Materials and Methods and either harvested
at con¯uence or switched to fresh supplemented F12 medium (F12), fusion medium (FM), or FM containing 1.6 mM EGTA (FM / 1.6
mM EGTA). Switched cultures were harvested after 48 hr.
b Fusion indexÐCell cultures were stained and nuclei counted as described under Materials and Methods. Results are expressed as the
mean { SEM of 20 ®elds (between 2000 and 3000 nuclei counted in total) at a magni®cation of 2001.
c Creatinine kinase activityÐActivity was determined as described under Materials and Methods and is expressed as the mean { SEM
n  3.
d b3 integrin subunit levelsÐb3 integrin subunit immunoreactive bands were visualized by ECL detection and quantitated as described
under Materials and Methods. Units are arbitrary and represent the pixel densities of the immunoreactive bands corrected for background.
Results are the mean { SEM of three trials. Numbers in parentheses represent mean pixel densities relative to con¯uent pixel density.
Preparation of RNA and Northern Blot Procedures Creatine Kinase Activity
Cells were scraped into ice-cold PBS and homogenized on icePolyadenylated RNA was extracted from cultures with the
with 40 strokes of a Dounce hand-held homogenizer (Table 1) orQuickPrep Micro mRNA Puri®cation kit (Pharmacia, Baie d'UrfeÂ ,
using a PRO 200 homogenizer (PRO Scienti®c Inc., Monroe, CT)Que.). RNA species were resolved in 1.5% agarose gels containing
at half-maximal speed for 5 sec on ice. Homogenates were centri-6.6% formaldehyde and transferred onto nylon membranes (Hy-
fuged and samples of the clari®ed supernatants were assayed forbond N, Amersham, Oakville, Ont.) by overnight capillary transfer.
creatine kinase activity by kit as per the manufacturer's instruc-The RNA was then cross-linked to the membrane by UV Stra-
tions (CK NAC-activated, MPR 1, Boehringer Mannheim, Laval,talinker-2400 (Stratagene, La Jolla, CA).
Que.). Samples of clari®ed supernatants were also assayed for pro-Northern blots were prehybridized, hybridized with radiolabeled
tein concentration by the DC microplate protein assay as abovecDNA probes, and washed as previously described (Blaschuk and
(Bio-Rad). Creatine kinase activity is expressed as mmole/min/mgHolland, 1994) with the exception that dextran sulfate (5 Prime to
soluble protein (International Units/mg protein).3 Prime Inc., Boulder, CO) was added to the hybridization buffer
to a ®nal concentration of 10%. cDNA probes used were for the
human b3 integrin subunit (a plasmid containing a cDNA insert Transfection of C2 Myoblasts
which encodes human GPIIIa was a gift of Dr. Peter J. Newman,
C2 myoblasts were plated at 1.5 1 105 cells per 35-mm dish inBlood Research Institute, Milwaukee, WI), human a5 integrin sub-
DMEM containing 10% fetal calf serum (standard growth medium)unit (GIBCO BRL, MD), rat myogenin (Wright et al., 1989), and
and were maintained at 377C in 5% CO2. They were transfectedGAPDH (a gift of Dr. K. Hastings, McGill University, Montreal,
24 hr after plating. b3-pcDNA3 DNA (1 mg) in 100 mL of Opti-Que.). cDNA probes were radiolabeled with [32P]dCTP (Amersham)
MEM reduced serum medium was mixed with 6 ml of lipofectamineusing an oligolabeling kit according to manufacturer's instructions
(Gibco/BRL) in 100 ml of Opti-MEM. After 30 min at room tempera-(Pharmacia). Unincorporated radiolabel was removed using Nick
ture, a further 0.8 ml of Opti-MEM was added to the mixture, theSpin columns (Pharmacia). Blots were exposed to Phosphorimager
cells were rinsed with 2 ml of Opti-MEM, and the lipofectamine/plates for 1 to 5 days and scanned (Phosphorimager, Molecular
DNA/Opti-MEM mixture was added. Plates were maintained inDynamics, Sunnyvale, CA). Radiolabeled bands were quanti®ed by
this mixture at 377C in 5% CO2 for another 24 hr, after which itImageQuant computer program (Molecular Dynamics). b3 integrin
was replaced with standard growth medium. Forty-eight hours aftersubunit and myogenin encoding mRNA levels were normalized
the transfection, the cells were detached with trypsin and replatedrelative to corresponding GAPDH mRNA levels.
into a 150-mm plate containing 650 mg/ml of active geneticin (Neo-
mycin or G418, Gibco/BRL No. 11811-023) in standard growth me-
dium. After 1 week of growth in this medium, the surviving cellsFusion Index
were replated in 1.4 mg/ml of geneticin at 103 cells per 150-mm
plate. After several days, colonies were harvested by localized tryp-Cells were ®xed in 2.5% glutaraldehyde and stained with Harris
hematoxylin and eosin by conventional methods. Nuclei were sinization (3 ml of 0.05% trypsin, 0.02% EDTA in Hepes-buffered
saline was added to each colony) were transferred to individualcounted by a JAVA video analysis system (Jandel Scienti®c). Be-
tween 2000 and 4500 nuclei were counted in total per culture dish. wells of a 24-well plate containing 1 ml of standard growth medium
per well. Selection with G418 was maintained. The clones wereThe fusion index is expressed as the percentage of total nuclei
found in myotubes, where myotubes are de®ned as having two or expanded in 35-mm plates, harvested, aliquoted, and stored frozen
in liquid nitrogen.more nuclei.
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native conditions cells were solubilized in 0.5 ml of ice-cold nonde-
naturing extraction buffer and the tubes were incubated with gentle
end over end mixing at 47C for 30 min. For extraction under dena-
turing conditions cells were solubilized in 0.5 ml of hot (1007C)
extraction buffer (150 mM NaCl, 0.5 mM CaCl2, 1% SDS, 0.05 M
Tris±HCl, pH 8.0) and the tubes were heated at 1007C for 5 min.
SDS was displaced from proteins (Hjerten et al., 1988) by adding
120 ml of 25% Triton X-100 (in 150 mM NaCl, 0.5 mM CaCl2, 1
mM trypsin inhibitor, 5 mM N-ethylmaleimide, 0.05 M Tris±HCl,
pH 8.0) and leaving the mixtures at room temperature for 30 min.
Washed anti-mouse-IgG-agarose suspension (30 ml) (Sigma No.
A3665) was added to each tube. Supernatants were collected by
centrifugation following a 10-min incubation at 47C. Anti-human
b3-integrin antibody (5 ml) (Serotec No. MCA 728, stock at 1 mg/
ml) was added to each tube. Tubes were incubated for 2 hr at 47C
with occasional mixing. Washed anti-mouse IgG agarose (25 ml)
was added to each tube and the incubation was continued overnight
at 47C. The beads were collected by centrifugation and washed four
times with 1 ml of cold nondenaturing extraction buffer (with a 5-
min incubation at 47C with end over end mixing in each wash step)FIG. 1. Pattern of expression of av integrin subunits in human
and twice with extraction buffer without Triton X-100. Beads weremuscle cells during growth and differentiation. Homogenates were
collected by centrifugation and bound proteins were eluted at 657Cprepared from human muscle cells which had been cultured to
for 15 min in 50 ml of SDS sample buffer without reducing agent.subcon¯uence (SC) and con¯uence (C) in growth medium and from
cells further cultured in fusion medium for 24 hr (24 h), 48 hr (48
h), and 6 days to the appearance of mature myotubes (MT). Western
blots were prepared and probed as described under Materials and
Methods. Bands corresponding to the av subunit were detected
by ECL (a) and quantitated by JAVA video analysis as graphically
represented (b). Units obtained by JAVA analysis are arbitrary and
represent the pixel densities of immunoreactive bands as corrected
for background. Results (b) are the mean { SEM of 5 trials. Protein
molecular weight markers corresponding to myosin heavy chain
(200 kDa) and phosphorylase b (97.4 kDa) are indicated in A. The
arrow in B indicates the stage of culture at which cells were
switched to fusion medium.
Immunoprecipitation and Iodination of Integrins
C2 myoblasts and b3-integrin-transfected C2 myoblasts were
each grown to con¯uence in a 100-mm plate in standard growth
medium. The cells were washed three times with PBS. For samples
that were not to be iodinated, cells were scraped with a rubber
policeman in 1 ml of ice-cold nondenaturing extraction buffer (150
mM NaCl, 0.5 mM CaCl2, 1% w/v Triton X-100, 1 mM trypsin
inhibitor, 5 mM N-ethylmaleimide, 0.05 M Tris±HCl, pH 8.0) and
incubated with gentle end over end mixing at 47C for 30 min. The FIG. 2. Pattern of expression of b3 integrin subunits in human
muscle cells during growth and differentiation. Homogenates weremixtures were centrifuged at 15,000g for 5 min and the superna-
tants transferred to 1.5-ml tubes. Subsequent steps were as de- prepared from human muscle cells which had been cultured to
subcon¯uence (SC) and con¯uence (C) in growth medium and fromscribed below for immunoprecipitation of iodinated samples ex-
tracted under nondenaturing conditions. cells further cultured in fusion medium for 24 hr (24 h), 48 hr (48
h), and 6 days to the appearance of mature myotubes (MT). WesternCells to be iodinated were detached from the plate by incubation
with 0.5 mM EDTA in PBS. The cells were collected by centrifuga- blots were prepared and probed as described under Materials and
Methods. Bands corresponding to the b3 subunit were detectedtion and resuspended in 0.5 ml of PBS containing 1 mM MgCl2 and
1 mM CaCl2. Cells (4 1 105 cells in 1 ml) were added to eppendorf by ECL (a) and quantitated by JAVA video analysis as graphically
represented (b). Units obtained by JAVA analysis are arbitrary andtubes. Two Iodobeads (Pierce No. 28665) and 300 mCi of NaI125
(ICN) were added to each tube. Tubes were incubated at room represent the pixel densities of immunoreactive bands as corrected
for background. Results (b) are the mean { SEM of 5 trials. Proteintemperature for 15 min with end over end mixing. Iodobeads were
removed and the contents of each tube were divided equally into molecular weight markers corresponding to myosin heavy chain
(200 kDa) and phosphorylase b (97.4 kDa) are indicated in A. Thetwo new tubes, to permit extraction of cells under either native or
denaturing conditions. Cells were collected by centrifugation at arrow in B indicates the stage of culture at which cells were
switched to fusion medium.300g for 1 min and washed twice with PBS. For extraction under
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FIG. 4. The effects of BUdR treatment on levels of b3 integrin
FIG. 3. Quantitation of expression of b3 integrin and a5 inte- subunit mRNA and myogenin mRNA in human muscle cells dur-
grin subunits in human muscle cells treated with and without ing growth and differentiation. Poly(A)/ mRNA was extracted from
BUdR. Homogenates were prepared from human muscle cells cells which had been cultured to con¯uence (C) in growth medium
which had been cultured to subcon¯uence (SC) and con¯uence or in growth medium with or without 6.5 mM BUdR and from cells
(C) in growth medium with or without 6.5 mM BUdR and from further cultured in fusion medium with or without 6.5 mM BUdR
cells further cultured in fusion medium with or without 6.5 mM for 24 hr (24), 48 hr (48), or 96 hr to the appearance of mature
BUdR for 24 hr (24), 48 hr (48), and 6 days to the appearance of myotubes (MT) in control cultures (myotubes were not formed in
mature myotubes (MT). Western blots were prepared and probed BUdR-treated cultures). Northern blots of the samples were probed
for a5 or b3 subunit as described under Materials and Methods. with cDNAs encoding b3 integrin and myogenin as described under
Immunoreactive bands were detected by ECL and quantitated Materials and Methods and quantitated using a phosphorimager.
by JAVA video analysis, as graphically represented. Units ob- Levels of b3 integrin subunit mRNA and myogenin mRNA are
tained by JAVA analysis are arbitrary and represent the pixel expressed relative to measured levels of GAPDH mRNA in the
densities of immunoreactive bands as corrected for background. corresponding lane. (A) Cells plated and maintained in the absence
(A) b3 integrin. (B) a5 integrin. Symbols: (l) 6.5 mM BUdR; (s) of BUdR. (B) Cells plated and maintained in the presence of 6.5 mM
no BUdR. BUdR. Symbols: (s) myogenin; (l) b3 integrin subunit.
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supplemented growth medium were harvested during both
rapid (subcon¯uence) and slow (con¯uence) stages of
growth. Subcon¯uence is de®ned as between 50 and 80%
con¯uence, while con¯uence refers to cultures which have
attained an even monolayer of cells. The latter is attained
within 3 to 4 days of seeding, depending on the initial seed-
ing density. Most clones of human satellite cells have a
doubling time between 18 and 20 hr (data not shown). Con-
¯uent cultures were induced to terminally differentiate by
switching to fusion medium which is lacking serum and
other factors required for the growth and proliferation of
these cells in vitro. Cultures were harvested following 24
hr, 48 hr, and 6 days in fusion medium. Fusion was usually
evident by 24 hr following the switch, with the appearance
of a few short, thin, multinucleated myotubes. At 48 hr and
beyond, multinucleated myotubes were long, thick, often
branching, and widely distributed in the culture plates.
Analysis of avb3 Integrin Expression in Human
Muscle Cells
The expression of avb3 integrin was examined by West-
ern blot analysis of homogenates isolated from cultures of
human satellite cells. Differences were seen in the pattern
of expression of the av subunit (Fig. 1) and the b3 subunit
(Fig. 2) during the growth and differentiation of human mus-FIG. 5. Western blot analysis of the expression of b3 integrin
subunit in human muscle cells treated with EGTA. Homogenates cle cells. The av subunit was expressed at a constant level
were prepared from human muscle cells either grown to con¯uence throughout the entire period examined, whereas levels of
in growth medium (a, lane 1; b, column C.) or grown to con¯uence the b3 subunit were highest in rapidly proliferating, subcon-
in growth medium, then switched to and maintained for 48 hr in ¯uent cultures and dramatically declined in cultures main-
one of the following: fresh growth medium (a, lane 2; b, column tained in fusion medium. These results suggest that levels
F12), fusion medium (a, lane 3, b, column FM), or fusion medium of avb3 integrin in differentiating muscle cultures will be
containing 1.6 mM EGTA (a, lane 4; b, column FM/ EGTA). West-
controlled by the availability of the b3 subunit.ern blots were prepared and probed for b3 integrin subunit as de-
scribed under Materials and Methods. Immunoreactive bands were
detected by ECL (a) and quantitated by JAVA video analysis as The Effect of Inhibition of Myogenic Terminal
graphically represented in (b). Units obtained by JAVA analysis are Differentiation on b3 Integrin Subunit Expression
arbitrary and represent the pixel densities of immunoreactive bands
as corrected for background. Results (b) represent the mean { SEM The availability of exogenous growth factors controls the
of 3 trials. Protein molecular weight marker for phosphorylase b onset of muscle cell terminal differentiation. Consequently,
(97.4 kDa) is indicated in a. the down-regulation of b3 subunit levels depicted in Fig. 2
may occur either as a consequence of depletion of growth
factors from the medium or by activation of the terminal
differentiation program. To determine whether down-regu-
Samples of eluate (15 ml) were subjected to SDS±PAGE as de- lation of avb3 integrin expression is a consequence of mus-
scribed above. For iodinated samples the gels were ®xed in 25%
cle cell terminal differentiation, we examined the patternisopropanol/10% acetic acid for 1 hr, dried, and exposed for 3 days
of developmental regulation of the b3 integrin subunit into Kodak XAR 5 ®lm using intensifying screens. For noniodinated
cultures grown in the presence of 5-bromo-2*-deoxyuridinesamples proteins were transferred electrophoretically to nitrocellu-
(BUdR). BUdR is a thymidine analog which has been shownlose and immunostaining of Western blots was performed as de-
scribed above. to inhibit the expression of myogenic regulatory factors and
to consequently block differentiation (Tapscott et al., 1989).
We have previously con®rmed that BUdR is an effective
inhibitor of myogenin expression in human satellite cellsRESULTS
and that BUdR (at the concentration used) is not cytotoxic
to these cells (Blaschuk and Holland, 1994).Expression of avb3 integrin was examined in cells har-
vested at different stages of growth and differentiation. For BUdR treatment had a marked effect on the expression
pattern of the b3 integrin subunit (Fig. 3). Following themost experiments, two stages of growth and three stages of
terminal differentiation were examined. Cultures grown in switch to fusion medium, levels of b3 subunit were down-
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regulated in control cultures, as previously observed (Fig. 2),
but remained elevated in BUdR-treated cultures. We have
previously used this approach to show that the down-regula-
tion of a5 integrin subunit expression that occurs in cul-
tured muscle cells following a switch to fusion medium is
a consequence of the withdrawal of serum growth factors,
rather than of the onset of muscle cell terminal differentia-
tion (Blaschuk and Holland, 1994). As shown in Fig. 3, in
contrast to the b3 subunit, levels of the a5 integrin subunit
decline markedly following a switch to serum-deprived fu-
sion medium, regardless of whether the cultures undergo
terminal differentiation (i.e., plus or minus BUdR). These
results suggest that in contrast to the a5 integrin subunit,
levels of the b3 integrin subunit are not directly controlled
by exogenous growth factors, and expression of the b3 sub-
unit is tightly coupled to myoblast terminal differentiation
regardless of the growth conditions.
Similar effects on expression of the b3 subunit by BUdR
treatment were also observed at the mRNA level (Fig. 4).
Levels of mRNA encoding the b3 subunit (as normalized to
corresponding levels of GAPDH mRNA) declined in control
cultures (Fig. 4A) but remained at high levels in BUdR-
treated cultures (Fig. 4B) following the switch to fusion me-
dium. The level of transcripts encoding myogenin, a marker
of terminal differentiation, increased in control cultures
(Fig. 4A) but not in BUdR-treated cultures (Fig. 4B), con-
®rming that BUdR effectively inhibited differentiation un-
der these conditions.
Inhibition of Fusion and the Effects on avb3
Integrin Expression
FIG. 6. Western blot analysis of the expression of human b3 inte-
BUdR inhibits both fusion and biochemical differentiation.grin subunit in mouse C2 myoblasts. (A) C2 myoblasts were trans-
Consequently, although this agent clearly affects levels of b3fected with full-length cDNA encoding the human b3 integrin sub-
unit and stably transfected clones were selected as described under
Materials and Methods. Homogenates were prepared from individ-
ual clones grown to near con¯uence and samples (12 mg protein)
were subjected to SDS/PAGE and transferred to nitrocellulose. con¯uence and were solubilized and immunoprecipitated with an-
Western blots were prepared and probed for the human b3 integrin tibodies directed against human b3 integrin as described under
subunit as described under Materials and Methods. Immunoreac- Materials and Methods. Immunoprecipitates were subjected to
tive bands were detected by ECL. Lanes 1 and 2, clones expressing SDS/PAGE and transferred to nitrocellulose, and the blots were
undetectable to very low levels of human b3 integrin. Lanes 3 and incubated with antibodies reactive with the human b3 integrin
4, clones expressing moderate levels of human b3 integrin. Lanes subunit (C) or antibodies reactive with both mouse and human av
5 and 6, clones expressing high levels of human b3 integrin. The integrin subunits (D). Immunoreactive bands were detected by
migration of molecular weight markers is shown in kDa on the ECL. Lane 1 (C and D), C2 myoblasts expressing human b3 integrin
scale at the left of the ®gure. (B) A comparison of the relative level subunit. Lane 2 (C and D), control C2 myoblasts. Lane 3 (C and D),
of ectopic expression of human b3 integrin in the clone shown in human skeletal muscle cells. The migration of molecular weight
A, lane 6, with the endogenous level of expression of the b3 subunit markers is shown on the scale at the left of the ®gure. Note a band
in subcon¯uent human skeletal muscle cultures. Samples of cul- corresponding to b3 integrin is seen in C at 97 kDa in both the
ture homogenate (12 mg protein) were subjected to SDS/PAGE and transfected C2 myoblasts and in human muscle cells (arrowheads)
transferred to nitrocellulose. Western blots were prepared and but not in control C2 myoblasts (lane 2). Two bands were seen in
probed for the human b3 integrin subunit as described under Mate- control C2 myoblasts but these were present in all immunoprecipi-
rials and Methods. Immunoreactive bands were detected by ECL. tates and are judged nonspeci®c. Bands corresponding in mobility
Lane 1, human muscle cell cultures. Lane 2, stably transfected to the av subunit are also seen both in the transfected C2 myoblasts
C2 myoblasts. (C and D) Western blot of immunoprecipitates of and in human muscle cells (arrowheads) but not in control C2
cultures of C2 myoblasts stably transfected with human b3 inte- myoblasts (lane 2) in D, showing that mouse av coprecipitates with
grin, of control C2 myoblasts, and of human skeletal muscle satel- human b3 in transfected C2 myoblasts. Note that the mouse and
lite cells, reacted with antibodies against the b3 integrin subunit human av subunits have slightly different mobilities in SDS/
PAGE.(C) or the av integrin subunit (D). Cultures were grown to near
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subunit expression, b3 subunit expression may be down-regu- Several stably transfected lines were isolated which were
resistant to high concentrations of G418 (1.4 mg/ml). West-lated either as part of the fusion process or as a consequence
of biochemical differentiation. To determine which of these ern blot analysis of these lines with an antibody speci®c for
the human b3 integrin subunit revealed that some lines hadpathways may regulate avb3 integrin expression, we exam-
ined the expression of the b3 integrin subunit in cultures low to undetectable levels of expression of the transfected
gene, whereas others had moderate to high levels of expres-induced to differentiate biochemically but in which fusion
was inhibited. Since myoblast fusion is known to be Ca2/ sion (Fig. 6A). The levels of expression for each of the clones
shown in Fig. 6 were reproducible and stable when the samedependent (Knudsen and Horwitz, 1977), we included EGTA
(a Ca2/ chelator) in the fusion medium used to induce differen- clones were reprobed after several further passages in vitro
(not shown). The level of expression of the human b3 inte-tiation (Table 1). EGTA at a ®nal concentration of 1.6 mM
was used for these experiments. This concentration of EGTA grin subunit in the most strongly expressing stably trans-
fected line was approximately equivalent to the level of b3was found to be the lowest in a range of concentrations tested
(1.5 to 2.0 mM) that could reversibly inhibit human muscle integrin subunit expression detected in prefusion human
muscle cultures (Fig. 6B). When the human b3 integrin sub-cell fusion while affecting neither biochemical differentiation
nor cell adhesion to culture plates. unit was immunoprecipitated from extracts of the trans-
fected cells, the mouse aV subunit coprecipitated, indicat-Fusion and CK activity were found to be low in con¯uent,
preswitch cultures and cultures switched to and maintained ing that mouse aV/human b3 integrin dimers can form in
these cells (Figs. 6C and 6D). Surface labeling of transfectedin fresh growth medium for an additional 48 hr (Table 1). As
expected, in cultures switched to fusion medium alone, both cells with 125I and immunoprecipitation further demon-
strated that the ectopically expressed human b3 integrinfusion and CK activity were quite pronounced. However, al-
though CK activity was also elevated in cultures switched subunit was present with the mouse aV subunit at the cell
surface (Fig. 7).to fusion medium containing EGTA, fusion was effectively
inhibited in EGTA-treated cultures. The fusion index was To determine the effect of overexpression of b3 integrin
on myoblast terminal differentiation, we analyzed the ex-only slightly higher than the fusion index of cultures switched
to fresh growth medium (Table 1). pression of creatine kinase (CK) in the stably transfected
myoblast lines. Lines with undetectable to very low levelsLevels of b3 integrin subunit expression were examined
under these conditions (Fig. 5, Table 1). Expression of this of expression of the b3 subunit (Figs. 8A and 8B, respec-
tively) differentiated normally. They showed increased lev-subunit was highest in con¯uent cultures but remained ele-
vated at near-con¯uent levels in cultures switched to fresh els of CK by 24±48 hr following the switch from growth
medium to fusion medium, and CK activity was at or closegrowth medium. In contrast, expression of the b3 integrin
subunit was considerably reduced (to 30±34% of con¯uent to maximal levels by 72±96 hr postswitch. In contrast, lines
expressing moderate levels of the human b3 subunit didlevels) in cultures switched to either fusion medium alone
or fusion medium containing EGTA. Since levels of the b3 not exhibit an increase in CK activity until 72 (Fig. 8C) to
96 (Fig. 8D) hr following the switch to fusion medium. Linessubunit were still down-regulated in differentiating cul-
tures in which fusion was inhibited, it can be concluded expressing high levels of the human b3 subunit showed no
detectable increase in CK activity throughout the entirethat down-regulation of expression is not related to the fu-
sion process, but is instead coupled to biochemical differen- time period measured (Figs. 8E and 8F). Visual inspection
revealed that biochemical and morphological differentia-tiation.
tion remained coupled in these cultures. The cells repre-
sented in panels A and B (Fig. 8) fused extensively, whereas
The Effect of Overexpression of the b3 Integrin there was no detectable myotube formation in the cells
Subunit on Myogenic Terminal Differentiation represented in panels E and F. A few myotubes were formed,
by 96 hr in fusion medium, in the cultures represented inFor these experiments, which involved a prolonged period
of selection of transfected cells to isolate stably transfected panels C and D.
cell lines, it was necessary to switch from primary cultures
of human muscle cells to a permanent muscle cell line.
We established by Northern blotting that mouse C2 myo- DISCUSSION
blasts (Yaffe and Saxel, 1977) undergo a decline in expres-
sion of transcripts encoding the b3 integrin subunit during
avb3 Integrin Levels Decline during Myogenesis
differentiation similar to that shown in Fig. 4 for human and Are Controlled by the Availability of the b3
muscle cells. C2 myoblasts were then transfected with the Subunit
expression vector pcDNA3 (Invitrogen Corp., San Diego,
CA) into which the complete coding sequence for human avb3 integrin has been identi®ed in a variety of cell types,
including endothelial, ®broblastic, smooth muscle, mela-b3 integrin was inserted downstream of the CMV promoter.
pcDNA3 contains a neomycin resistance gene which per- noma, osteosarcoma, neuroblastoma, and glioblastoma. In
this report we describe the expression of this integrin inmits the isolation of stably transfected lines by selection
for resistance to the neomycin analog G418 (GIBCO-BRL). developing skeletal muscle cells. We ®nd that while levels
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we investigated the effect of forced expression of the b3
integrin subunit on myogenesis. Ectopic expression of the
b subunit would be expected to result in the maintenance
of avb3 integrin at high levels. Forced expression of the b3
integrin subunit delayed or prevented myoblast fusion and
differentiation, suggesting that the down-regulation of b3
integrin expression which normally occurs during myoblast
terminal differentiation is an essential, and controlling, step
in this process.
We chose to express the human b3 integrin subunit in a
mouse muscle cell line because expression of the human sub-
unit can readily be detected using an antibody which does not
cross-react with the endogenous mouse b subunit. A similar
approach has been successfully used to analyze the effect of
ectopic expression of human a5 and a6 integrin subunits on
the terminal differentiation of quail myoblast cultures (Sastry
et al., 1996). Several factors argue against the possibility that
the effects of forced expression of the human b3 integrin sub-
unit on myogenesis re¯ect an unphysiological effect. First,
several independently isolated clones of transfected cells were
analyzed and the extent of inhibition of myogenesis in these
clones correlated well with their level of expression of the
exogenous b3 integrin subunit. This strongly argues against
a chance insertion of the exogenously introduced DNA into
a region of the genome critical for myogenesis in these clones.
Second, the level of expression of the exogenously introducedFIG. 7. Cell surface iodination of ectopically expressed human b3
b3 integrin subunit was within the normal range of expressionintegrin. Control C2 myoblasts (lanes 1 and 3) and C2 myoblasts
of the endogenous subunit by undifferentiated myogenic cells.ectopically expressing human b3 integrin (lanes 2 and 4) were iodin-
Thus, the highest level of expression of the exogenous b3ated, extracted under native (lanes 1 and 2) and denaturing (lanes
subunit detected in a stably transfected clone was similar to3 and 4) conditions, and immunoprecipitated with antibodies reac-
tive with the human b3-integrin subunit as described under Materi- that detected in prefusion human myoblasts. Finally, the exog-
als and Methods. Immunoprecipitates were subjected to SDS/PAGE enously introduced human b3 integrin subunit formed hetero-
and radioactive bands were detected by autoradiography. The mi- dimers with the endogenous mouse av subunit, which were
gration of molecular weight markers is shown on the scale at the present at the C2 myoblast cell surface.
left of the ®gure. Note that two labeled bands were detected in There are several ways in which an high level of expression
transfected C2 myoblasts precipitated under native conditions (lane of avb3 integrin (endogenous or ectopically induced) may neg-
2) with mobilities corresponding to av and b3 integrin (arrow- atively affect myogenesis. These include (i) ligand-mediated
heads). These bands were not present in immunoprecipitates from
effects on myoblast migration or proliferation; (ii) ligand-de-control C2 myoblasts (lane 1). In precipitations from cells extracted
pendent activation of a signal transduction pathway resultingunder denaturing conditions to dissociate a and b integrin subunits
in an intracellular event inhibitory to terminal differentiation,only the b3 subunit, which is the primary target of the antibody,
or (iii) an indirect effect due to modulation of the assemblyis precipitated (lane 4).
of other integrins which may be critically involved in myogen-
esis. The b3 integrin subunit is known to dimerize with only
two a subunits (Albelda and Buck, 1990), namely, av, which
is expressed by muscle cells, and aIIb (platelet GPIIb), whichof the av integrin subunit remain essentially invariant dur-
is not known to be expressed by muscle cells. In addition toing myogenesis, levels of the b3 integrin subunit are highest
dimerizing with the b3 integrin subunit, the av subunit canin proliferating, undifferentiated muscle cells and decline
also form functional dimers with b1 and b5 integrin subunitsmarkedly with the onset of terminal differentiation. Conse-
(Felding-Habermann and Cheresh, 1993). Sequestration of thequently, we can conclude that levels of avb3 integrin in
av subunit by forced expression of the b3 subunit might there-developing skeletal muscle cells will be limited by the avail-
fore indirectly affect the formation of avb1 and/or avb5 inte-ability of the b3 subunit.
grins. Further studies are needed to distinguish between these
possibilities.
Myogenesis Is Inhibited by Forced Expression of b3 Integrin and a5 Integrin Expression Are
the b3 Integrin Subunit Controlled by Distinct Mechanisms
Since b3 integrin subunit levels may be limiting for the The terminal differentiation of muscle cells in culture is
induced by the withdrawal of serum and various otherformation of avb3 integrin in differentiating muscle cells
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FIG. 8. Induction of creatine kinase activity by C2 myoblast clones stably transfected with the human b3 integrin subunit. The clones
described in A were grown to near con¯uence in standard growth medium and then switched to fusion medium (FM) to induce differentia-
tion. Cells were harvested after incubation in FM for 24, 48, 72, or 96 hr, as indicated in each panel, and were assayed for creatine kinase
(CK) activity as described under Materials and Methods. The panels correspond to the clones shown A as follows: A, lane 1. B, lane 2. C,
lane 3. D, lane 4. E, lane 5. F, lane 6.
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Blaschuk, K. L., and Holland, P. C. (1994). The regulation of a5b1growth factors. Consequently, the observed decline in b3
integrin expression in human muscle cells. Dev. Biol. 164, 475±subunit expression observed in cultured cells could be
483.caused either directly by the withdrawal of growth factors or
Boettiger, D., Enomoto-Iwamoto, M., Yoon, H., Hofer, U., Menko,as a consequence of the process of terminal differentiation.
A., and Chiquet-Ehrisman, R. (1995). Regulation of integrin a5b1When cultures were inhibited from differentiating by
af®nity during myogenic differentiation. Dev. Biol. 169, 261±
growth in BUdR, b3 subunit expression (at both the mRNA 272.
and protein levels) was maintained at a high level when Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A.,
cultures were switched to serum- and growth factor-de- Hu, T., Klier, G., and Cheresh, D. A. (1994). Integrin avb3 antago-
prived fusion medium. Consequently, and in marked con- nists promote tumor regression by inducing apoptosis of angio-
trast to the a5 integrin subunit (Blaschuk and Holland, genic blood vessels. Cell 79, 1157±1164.
Champaneria, S., Holland, P. C., Karpati, G., and GueÂrin, C. (1988).1994), expression of the b3 integrin subunit is not regulated
Developmental regulation of cell-surface glycoproteins in clonaldirectly by the availability of growth factors but appears to
cultures of human skeletal muscle satellite cells. Biochem. Cellbe tightly coupled to the myogenic terminal differentiation
Biol. 67, 128±136.program.
Charo, I. F., Nannizzi, L., Smith, J. W., and Cheresh, D. A. (1990).A model consistent with the above observations on the
The vitronectin receptor avb3 binds ®bronectin and acts in con-regulation of a5 and b3 subunit expression and the demon-
cert with a5b1 in promoting cellular attachment and spreadingstrated role of each in controlling the onset of myogenesis is on ®bronectin. J. Cell Biol. 111, 2795±2800.
to postulate that each mediates a transmembrane signaling Cheng, Y-F., Clyman, R. I., Enenstein, J., Waleh, N., Pytela, R., and
event inhibitory to differentiation. A decline in a5 integrin Kramer, R. H. (1991). The integrin complex avb3 participates in
levels in response to local depletion of growth factors would the adhesion of microvascular endothelial cells to ®bronectin.
Exp. Cell Res. 194, 69±77.be expected to diminish this inhibitory signal and be condu-
Chung, C. Y., and Kang, M-S. (1990). Correlation between ®bro-cive to the cessation of proliferation and the initiation of
nectin and its receptor in chick myoblast differentiation. J. Cell.myoblast terminal differentiation (Blaschuk and Holland,
Physiol. 142, 392±400.1994; Sastry et al., 1996). This in turn would normally lead
Clyman, R. I., Mauray, F., and Kramer, R. H. (1992). b1 and b3 inte-to a decrease in the expression of b3 integrin as an integral
grins have different roles in the adhesion and migration of vascu-part of the myogenic terminal differentiation program. The
lar smooth muscle cells on extracellular matrix. Exp. Cell Res.present results suggest that down-regulation of b3 integrin
200, 272±284.
expression is an essential step in the completion of my- Cohen, R., Paci®ci, M., Rubinstein, N., Biehl, J., and Holtzer, H.
oblast terminal differentiation and show that forced expres- (1977). Effect of a tumour promoter on myogenesis. Nature 266,
sion of the b3 subunit can maintain myoblasts in an undif- 538±540.
ferentiated state. Delannet, M., Martin, F., Bossy, B., Cheresh, D. A., Reichardt, L. F.,
and Duband, J. L. (1994). Speci®c roles of the avb1 , avb3 and avb5
integrins in avian neural crest cell adhesion and migration on
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